A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica

A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica

Abstract Objective As phase III trials have shown interest in innovative but expensive drugs in the treatment of neuromyelitis optica spectrum disorder (NMOSD), data are needed to clarify strategies in the treatment of neuromyelitis optica (NMO). This meta‐analysis compares the efficacy of first‐lin...

Full description

Bibliographic Details
Main Authors: Jonathan Giovannelli, Jonathan Ciron, Mikael Cohen, Ho‐Jin Kim, Su‐Hyun Kim, Jan‐Patrik Stellmann, Ingo Kleiter, Morgan McCreary, Benjamin M. Greenberg, Romain Deschamps, Bertrand Audoin, Elisabeth Maillart, Caroline Papeix, Nicolas Collongues, Bertrand Bourre, David Laplaud, Xavier Ayrignac, Françoise Durand‐Dubief, Aurélie Ruet, Sandra Vukusic, Romain Marignier, Luc Dauchet, Hélène Zephir, NEMOS (Neuromyelitis Optica Study Group in Germany), NOMADMUS (Neuromyelitis Optica study Group in France), OFSEP (Observatoire Français de la Sclérose en Plaques) investigators
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51451

Internet

https://doi.org/10.1002/acn3.51451

Similar Items